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Abstract Nowadays, in forensic laboratories, heroin pro-
filing is frequently carried out by gas chromatography
coupled with mass spectrometry (GC-MS). This analytical
technique is well established, provides good sensitivity and
reproducibility, and allows the use of large databases.
Despite those benefits, recently introduced analytical
techniques, such as ultra-high-pressure liquid chromatography
(UHPLC), could offer better chromatographic performance,
which needs to be considered to increase the analysis
throughput for heroin profiling. With the latter, chromato-
graphic conditions were optimized through commercial
modeling software and two atmospheric pressure ionization
sources were evaluated. Data obtained from UHPLC–MS/MS
were thus transferred, thanks to mathematical models to
mimic GC-MS data. A calibration and a validation set of
representative heroin samples were selected among the
database to establish a transfer methodology and assess the
models’ abilities to transfer using principal component
analysis and hierarchical classification analysis. These abili-
ties were evaluated by computing the frequency of successful
classification of UHPLC–MS/MS data among GC-MS
database. Seven mathematical models were tested to adjust
UHPLC–MS/MS data to GC-MS data. A simplified mathe-
matical model was finally selected and offered a frequency of
successful transfer equal to 95%.
Keywords Heroin profiling . Principal component
analysis . Hierarchical classification analysis .
UHPLC–MS/MS .Multiple linear regression . Transfer
Introduction
The profiling of heroin follows several objectives. One of
them is the establishment of links between samples that
have been seized at different locations in order to
highlight information that may be used to decipher drug
trafficking organization and distribution pattern for
supporting law enforcement investigation. The improve-
ment and quickening of drug profiling processes remains
a constant preoccupation to provide timely results
necessary for an effective battle against drug manufac-
turers and drug dealers. Heroin (diacetylmorphine), is a
semi-synthetic compound derived from morphine, which
is extracted from Papaver somniferum. During the
extraction process, many compounds are simultaneously
extracted, which can also be transformed during the
acetylation of morphine. Therefore, proportions of co-
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extracted molecules vary depending on the method of
cultivation and the acetylation process. Subsequent cuts
(solid dilution) do not affect the relative proportions of
heroin and co-extracted molecules, and a comparison of
seized drugs is possible to highlight traffic networks for
providing both tactical and strategic intelligence [1–8].
Today, the profiling of heroin is generally performed
by gas chromatography coupled with mass detection
(GC-MS) [9]. To increase the volatility of those molecules
for GC-MS analysis, a derivatization step with N-methyl-N-
(trimethylsilyl)trifluoroacetamide (MSTFA) is mandatory.
This derivatization step takes about an hour, allowing
compounds to be analyzed by GC-MS in <25 min (see
Fig. 1). An existing GC-MS database combines results of
859 samples of heroin seized in a French-speaking part
of Switzerland during the last 2 years (2008–2009). In
this database, peak areas of seven compounds are
compiled: meconine (MEC), acetylcodeine, acetylthebaol,
6-monoacetylmorphine (6-MAM), heroin, papaverine,
and noscapine (NOS). GC-MS profiling methodology
involves, among others, the standardization of data and
the use of principal component analysis (PCA). Despite
the quality of profiling results obtained by Esseiva et al.
[2, 9] and Dujourdy et al. [3], the complete GC-MS
procedure is long and some recent analytical techniques
may be envisaged to conduct heroin profiling analysis.
In these last years, liquid chromatography (LC) has
strongly evolved and numerous manufacturers offer new
equipment and chromatographic columns allowing very fast
and/or highly efficient separations [10–13]. In our opinion,
those benefits have to be considered for heroin profiling. In
this paper, ultra-high-pressure liquid chromatography
(UHPLC) was selected to investigate a possible transfer of
the conventional heroin profiling method toward alterna-
tive, rapid, and selective LC determinations. Besides, the
applicability of UHPLC–MS/MS for heroin profiling was
already discussed in the work of Lurie and Toske [14].
Today, it is admitted that to maintain a harmonized database
based on GC-MS determination, it is compulsory to adopt
strictly similar analytical conditions (i.e., the same brand of
GC-MS, liner, column, etc.). This approach’s capability is
thus somehow limited when one needs to renew an old
instrument or replace it with a more efficient analytical
technique (e.g., fast separation). Because relative peak
intensities are often different, it is then necessary to create
a new database and consequently reset the memory of the
previous knowledge. In order to overcome this problem, an
innovative data treatment methodology was proposed. In
the present study, the major challenge was to demonstrate
the possibility of feeding a common conventional GC-MS
database with data coming from a different analytical
technique (i.e., UHPLC–MS/MS).
Experimental
All samples were obtained in street-seized powdered form.
Samples were seized by the Swiss police in 2008 and 2009.
Chemicals and reagents
For UHPLC–MS/MS experiments, formic acid and meth-
anol (MeOH) were of ULC/MS grade and purchased
from Biosolve (Valkenswaard, the Netherlands). Ammo-
nium hydroxide was provided by Sigma-Aldrich (Buchs,
Switzerland). Water was obtained from a Milli-Q Water
Purification System from Millipore (Bedford, MA, USA).
Ammonia buffer, 10 mM, was prepared with an adapted
volume of ammonium hydroxide and the pH adjusted to
8.0, 8.5, and 9.0 with formic acid. pH was measured
with a Metrohm pH meter (Herisau, Switzerland), and
the prepared buffer had a buffer capacity higher than
5 mM/pH unit. For GC-MS experiments, chloroform,
pyridine, heneicosane, and MSTFA were purchased from
Fluka (Sigma-Aldrich).
GC-MS instrumentation
An Agilent Technologies 6890A gas chromatograph inter-
faced with an Agilent Technologies 5975C mass selective
detector was used for GC-MS analyses. Analytes were
separated on a non-polar DB-5 ms capillary column (30-m
length, 0.25-mm i.d., and 0.25-μm film thickness, J&W
Fig. 1 Total ion chromatogram of a heroin sample obtained by GC-
MS. Column: non-polar DB-5 ms capillary column (30-m length,
0.25-mm i.d., and 0.25-μm film thickness), the initial oven
temperature was set at 150 °C, first raised to 250 °C (at 8 °C/min)
and then to 320 °C (at 6 °C/min), helium flow=1 mL/min. Peak
identity (numbered in accordance with UHPLC elution order): 1
paracetamol, 2 caffeine, 3 meconine, 6 6-monoacetylmorphine,
8 diacetylmorphine, 9 acetylcodeine, 10 papaverine, 11 noscapine,
12 acetylthebaol, IS internal standard
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Scientific, Agilent Technologies, Palo Alto, CA, USA). The
initial oven temperature was 150 °C, first raised to 250 °C
(at 8 °C/min) and then to 320 °C (at 6 °C/min) for a total
run of 24.17 min. Two microliters of each sample was
injected using helium as carrier gas (constant flow mode,
1 mL/min). Injections were carried out in split mode
using a split/splitless liner packed with glass wool
(Agilent Technologies, no. 5183-4711) with a split ratio
of 1:50. Applied temperatures were: 250 °C for injector,
280 °C for transfer line, 230 °C for ion source, and 150 °C
for quadrupole. Data were acquired in the full scan mode
(30–450 m/z mass range) with a sampling rate of 3
(1.77 scans per second). Data were then analyzed using
MSD Enhanced ChemStation v. D.02.00.275 (Agilent
Technologies). For the determination of the chemical
signature of heroin samples, peak areas of targeted ions
were studied (see Table 1).
UHPLC–MS/MS instrumentation
UHPLC–MS/MS experiments were performed on a Waters
Acquity UPLC system (Milford, MA, USA) hyphenated
with a triple quadrupole TQD mass spectrometer from
Waters (Acquity TQD detector). The UPLC instrument
included a binary pumping system with a maximum flow
rate of 2 mL/min, an autosampler with an injection loop
volume of 2 μL used in full loop conditions, a UV–Vis
programmable detector, and a column manager that
included a column oven set at 30 or 50 °C. Separation
was carried out on Acquity BEH C18 50×2.1 mm, 1.7 μm,
and Acquity BEH Shield RP18 50×2.1 mm, 1.7 μm, both
provided by Waters. The following solvent system was
considered: A = ammonium buffer 10 mM; B = methanol
or acetonitrile. Optimal chromatographic conditions were
found, thanks to HPLC modeling software (Osiris 4.1.1.2,
Datalys, Grenoble, France). For this purpose, analytes were
individually injected at 500 μL/min using two gradient runs
that differ in slope, namely, 5% to 95% B linear gradient in
14.4 and 4.8 min, respectively. Optimal chromatographic
conditions at various pH, mobile phases, and stationary
phases were determined for tmin (i.e., the minimum
acceptable elution time) equal to 0.36 min and tmax (i.e.,
the maximum acceptable elution time) of 3.8 min.
The TQD operated at single mass resolution of m/z 0.7
full width at half-maximum and possesses an upper mass
limit of m/z 2,000. The dual atmospheric pressure chemical
ionization (APCI)/electrospray ionization (ESI) source was
used in the ESI positive mode and ionization parameters,
cone voltages, and collision energies optimized by infusing
each compound (1 μg/mL) in 30:70 MeOH/water at a flow
rate of 500 μL/min. Optimal cone voltages and collision
energies values were summarized in Table 2. The capillary
voltage and the source extractor voltage were set at 3,000
and 3 V, respectively. The source temperature was main-
tained at 150 °C, the desolvatation gas temperature and
flow at 400 °C and 800 L/h, respectively, and the cone
gas flow at 50 L/h. MS/MS detection was carried out in
the multiple reaction monitoring (MRM) mode and the
transitions also indicated in Table 2.
The collision gas flow was set at 0.2 mL/min of argon
and entrance and exit potentials, respectively adjusted to 1
and 0.5 V. Some experiments were also carried out with a
dual APCI/atmospheric pressure photo-ionization (APPI)
source used in the positive APPI mode. The parameters for
APPI source were the following: the repeller and the source
extractor voltage were set at 1,000 and 3 V, respectively.
The source temperature was maintained at 120 °C, the
APCI/APPI probe temperature and flow at 550 °C and
300 L/h, respectively, and the cone gas flow at 10 L/h. Data
acquisition, data handling, and instrument control were
performed by Masslynx v4.1 Software.
Sample preparation
For GC-MS, three replicates of each heroin sample (8 mg
each) were weighed with a MX5 microbalance (Mettler
Toledo, Columbus, OH, USA). Each replicate was
extracted in 500 μL of a solution containing 1 mg/mL of
heneicosane (Internal Standard) in a mixture of chloroform
and pyridine (5:1, v/v). Derivatization was performed by
adding 100 μL of MSFTA followed by heating at 80 °C for
60 min. Finally, an aliquot was placed into a vial for
injection in the GC system. Each replicate was injected
once and the mean peak area (i.e., mean on the three
replicates) was considered for calculation.
For UHPLC–MS/MS, a stock solution at 1 mg/mL was
prepared by dissolving 1 mg of each heroin sample
(weighted on a Mettler Toledo MX5 microbalance) in
1 mL of MeOH. Then, an aliquot of 100 μL was diluted
with 200 μL of MeOH and 700 μL of water for injection in
Table 1 List of the targeted ions for each compound extracted for the
determination of the chemical signature of heroin samples in GC-MS
No. Compound tR (min) Target ion (m/z)
3 Meconine 6.7 194.1
9 Acetylcodeine 15.6 341.2
12 Acetylthebaol 15.8 254.1
6 6-MAM 16.1 399.3
8 Diacetylmorphine 17.0 369.2
10 Papaverine 19.2 338.2
11 Noscapine 22.8 220.1
Peak numbering was done in accordance with UHPLC elution order
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the UHPLC system. Heroin samples were freshly diluted in
the appropriate solution just before analyses in order to
avoid the hydrolysis of alkaloids.
Transfer methodology
To introduce the problematic encountered in the present
study, a simple example can be taken, namely, the
comparison of peak areas obtained by two analytical
techniques. If standard reference is available and if no
formal quantitative determination is required, the transfer
methodology can be simply based on the comparison of
both calibration curves (i.e., the relationship between
concentration and analytical response in a given concentra-
tion range). But when standard reference is not available, it
is mandatory to establish the mathematical relationship
linking peak areas coming from both techniques (i.e.,
transfer rules) by the use of various unknown concentration
samples. The case study dealing with the transfer of
conventional GC-MS heroin profiling to UHPLC–MS/MS
was very similar to this scenario, but seven compounds
were involved. Thus, seven mathematical equations had to
be established to transfer peak areas of the seven com-
pounds and introduce heroin profiles corresponding to each
investigated sample in the GC-MS database using peak
areas coming from UHPLC–MS/MS. The developed
methodology allowed converting UHPLC–MS/MS peak
areas in “GC-like” data for their implementation in the
original GC-MS database. The following sections describe
the steps to successfully achieve this transfer and evaluate
its validity. The corresponding flowchart is depicted in
Fig. 2.
GC-MS data
The GC-MS database consists of the aforementioned seven
compound peak areas for 859 heroin samples. For each
heroin sample, peak areas were normalized by dividing
them by their sum to balance the weight of each variable
and compensate the variability of MS data intensity.
Subsequently, unit variance scaling was performed for each
compound; relative areas were centered and reduced by
subtracting the mean and dividing by the standard devia-
tion. This variance scaling step is mandatory to find reliable
projections.
UHPLC–MS/MS data
For this step, 58 heroin samples were selected by a
stratified random sampling. The strata were the clusters
coming from GC-MS sample classifications obtained by a
previous work [9]. This sample set was divided in a
calibration set (36 samples) allowing to fit transfer models
and a validation set (22 samples) used to estimate predictive
abilities of the transfer models. These heroin samples were
analyzed by UHPLC–MS/MS and peak areas were normal-
ized, centered, and reduced in the same way as GC-MS data
(see “GC-MS data”). The GC-MS database was then
divided into three subsets: the GC-MS calibration set data
(i.e., the 36 heroin samples included in the calibration set,
analyzed by GC-MS), the GC-MS validation set data (i.e.,
the 22 heroin samples, included in the validation set,
analyzed by GC-MS), and the reduced GC-MS database
(containing the data of the 801 heroin samples analyzed by
GC-MS which are neither in the calibration nor in the
validation set).
Table 2 Molecular weights, MS/MS transitions, dwell times, optimal cone voltages, and collision energies for the investigated compounds during
the profiling of unknown heroin samples with UHPLC–MS/MS
No. Compound tR (min) MW MS/MS transitions Dwell time (ms) Cone voltage (V) Collision energy (V)
3 Meconine 0.83 194.0 195.0>162.0 40 30 20
195.0>180.0 40 30 20
6 6-MAM 1.67 327.3 328.3>165.2 5 40 40
328.3>211.3 5 40 25
8 Diacetylmorphine 2.2 369.4 370.4>165.3 5 40 50
370.4>268.3 5 40 30
9 Acetylcodeine 2.38 341.3 342.3>165.3 5 40 50
342.3>225.3 5 40 25
10 Papaverine 2.58 339.3 340.3>171.0 5 45 40
340.3>202.5 5 45 25
11 Noscapine 3.21 413.3 414.3>220.3 5 35 20
414.3>353.3 5 35 25
12 Acetylthebaol 3.84 296.0 297.0>223.3 50 20 10
297.0>255.3 50 20 10
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Transfer
As the objective was to predict peak areas that would have
been obtained by GC-MS from those obtained in UHPLC–
MS/MS, model responses were GC-MS peak areas. For
each heroin sample, seven mathematical models were
employed to transform each peak area. For instance,
noscapine area obtained by UHPLC–MS/MS (NOSUHPLC)
was transformed, using a selected transfer model, into a
“GC-like” noscapine area (NOSGC-like) which needs to
be as close as possible to the noscapine area obtained in
GC-MS (NOSGC).
Mathematical models
Numerous mathematical models were considered, including
the simplest mathematical approaches, such as linear,
quadratic, or cubic models, but also more complex such
Fig. 2 Flowchart of the
methodology used in the
present study
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as poly-linear or poly-quadratic models, as presented in
Table 3 where, for the sake of clarity, only the example of
one analyte (noscapine) is presented.
Mathematical models can be classified into two sets. The
first one includes simple models (i.e., linear, quadratic, and
cubic models) which only take into account the predicted
variable (e.g., only NOSUHPLC and higher order effects
were used to predict NOSGC). The second set contains the
models which use all the effects (i.e., the mathematical
terms) to predict one variable (e.g., all the UHPLC–MS/MS
peak areas were used to predict NOSGC). The poly-linear
model takes into account areas (neither squared nor cubed
areas) of all compounds to predict one of them. The poly-
quadratic model also considers the influence of the
squared areas of other compounds. The complete model
included the cross-terms (e.g., NOSUHPLC⋅MECUHPLC)
and the ones containing squared terms (e.g. NOSUHPLC⋅
MECUHPLC
2 and NOSUHPLC
2⋅MECUHPLC). This model was
named “complete” because it consists of 34 mathematical
terms for a maximum of 35 since one degree of freedom
was necessary to the error estimation, ε. To simplify the
complete models, Pareto analyses were carried out on each
complete model. In this analysis, coefficients of each term
(β0, β1…β33) were squared and divided by the sum of the
squared β to obtain the relative contribution of each term
(i.e., relative β). The terms were then sorted according to
their influence (i.e., the weight) to the goodness of fit. As
depicted in Fig. 3 for acetylthebaol, many mathematical
terms had a relatively small contribution and were removed
from the mathematical model to avoid overfitting. Finally,
the most contributive mathematical terms were selected to
create the simplified models with the following criteria:
Contributive terms were selected until the cumulative
response explanation reached 80%. In addition, poly-
linear, poly-quadratic, and complete modelings were
Fig. 3 Example of Pareto analysis for the complete model with
acetylthebaol. The red curve depicts the cumulative response
explanation. The red dashed vertical line represents the limit of
selection. In this example, the most explanatory terms (left of the red
vertical line) were selected to create the simplified model
Table 3 Mathematical models tested for the transfer to GC-MS database (noscapine as example)
Name Model
Linear NOSGC ¼ b1  NOSUHPLC þ b0
Quadratic NOSGC ¼ b2  NOSUHPLC2 þ b1  NOSUHPLC þ b0
Cubic NOSGC ¼ b3  NOSUHPLC3 þ b2  NOSUHPLC2 þ b1  NOSUHPLC þ b0
Poly-linear
NOSGC ¼ b1  NOSUHPLC þ b4 MECUHPLC þ b5  ACUHPLC þ b6  AcTBUHPLC þ b7 MAMUHPLC
þb8  DAMUHPLC þ b9  PAPUHPLC þ b0
Poly-quadratic
NOSGC ¼ b1  NOSUHPLC þ b4 MECUHPLC þ b5  ACUHPLC þ b6  AcTBUHPLC þ b7 MAMUHPLC
þb8  DAMUHPLC þ b9  PAPUHPLC þ b10  NOSUHPLC2 þ b12 MECUHPLC2 þ b13  ACUHPLC2
þb14  AcTBUHPLC2 þ b15 MAMUHPLC2 þ b16  DAMUHPLC2 þ b17  PAPUHPLC2 þ b0
Complete
NOSGC ¼ b1  NOSUHPLC þ b4 MECUHPLC þ b5  ACUHPLC þ b6  AcTBUHPLC þ b7 MAMUHPLC
þb8  DAMUHPLC þ b9  PAPUHPLC þ b2  NOSUHPLC2 þ b10 MECUHPLC2 þ b11  ACUHPLC2
þb12  AcTBUHPLC2 þ b13 MAMUHPLC2 þ b14  DAMUHPLC2 þ b15  PAPUHPLC2
þb16  NOSUHPLC MECUHPLC þ b17  NOSUHPLC MECUHPLC2 þ b18  NOSUHPLC2 MECUHPLC
þb19  NOSUHPLC  ACUHPLC þ b20  NOSUHPLC  ACUHPLC2 þ b21  NOSUHPLC2  ACUHPLC
þb22  NOSUHPLC  AcTBUHPLC þ b23  NOSUHPLC  AcTBUHPLC2 þ b24  NOSUHPLC2  AcTBUHPLC
þb25  NOSUHPLC MAMUHPLC þ b26  NOSUHPLC MAMUHPLC2 þ b27  NOSUHPLC2 MAMUHPLC
þb28  NOSUHPLC  DAMUHPLC þ b29  NOSUHPLC  DAMUHPLC2 þ b30  NOSUHPLC2  DAMUHPLC
þb31  NOSUHPLC  PAPUHPLC þ b32  NOSUHPLC  PAPUHPLC2 þ b33  NOSUHPLC2  PAPUHPLC
þb0
Simplified Terms of the complete model selected with the Pareto analysis
Mathematical terms were labeled according to the compound, with subscripts corresponding to the analytical technique
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achieved through a stepwise regression that selected the
terms, maximizing the adjusted determination coefficients
(adjusted R2) [15]. See the Appendix for the complete
equations of the seven simplified models.
Multiple linear regressions, model adjustment,
and evaluation
The adjustments of mathematical models were carried out
by performing multiple linear regressions (MLR) of the
UHPLC–MS/MS calibration set against the GC-MS cali-
bration set. To evaluate the quality of MLRs, the mean
adjusted R2 were calculated (i.e., for a given tested model,
the mean adjusted R2 obtained for each compound).
Furthermore, the prediction coefficients (Q2) were also
approximated using a leave-n-out cross-validation calcula-
tion (with n=30% of the calibration set size). Thus, 11
samples were randomly removed from the calibration set to
create a temporary set. This set was considered to adjust the
multiple linear models, while the remaining calibration
samples were used to estimate Q2. The procedure was
repeated 250 times for each model in order to obtain a
robust estimation of Q2. Finally, using the adjusted models,
UHPLC–MS/MS calibration set and UHPLC–MS/MS
validation set were respectively transformed into the
“GC-like” calibration set and the “GC-like” validation set
(i.e., back-calculated GC-MS peak areas).
Data clustering
During the heroin profiling process, samples are generally
classified to highlight connections between samples. In
the present study, the clustering procedure consisted in a
sequential unsupervised multiway data analysis, as
schematized in Fig. 4. PCA was initially carried out to
select the principal components (PCs) explaining at least
95% of the initial data variance. This step mainly
consisted in data cleaning since the non-selected PCs
mainly correspond to non-significant variability. Then, a
hierarchical clustering analysis (HCA) was performed
using the sample coordinates in the space of the selected
PCs as described by Stella et al. [16] and Boccard et al.
[17]. HCA was accomplished with the Euclidean distances
and the Ward algorithm [18]. This corresponds to a global
PCA–HCA, carried out on the reduced GC-MS database
within which GC-MS data and “GC-like” data of one
tested heroin sample were added (803 samples).
In the resulting dendrogram, the last step was the
selection of a subset comprising at least 50 heroin samples
in the immediate neighborhood of the tested “GC-like”
sample. On this subset, a similar PCA–HCAwas performed
to refine the evaluation of the sample similarity in the
selected cluster and thus increase the predictions accuracy.
This corresponds to a local PCA–HCA, carried out on the
most similar samples of the tested “GC-like” sample.
Significant clustering height calculation
To obtain a clustering after HCA, the dendrogram was cut
at a given height. In the present study, this height was
calculated using the freely available “pvclust” R-package so
that the p values for each cluster were calculated by
multiscale bootstrap resampling [19]. The reduced GC-MS
database (801 samples) was used to estimate this cutting
Fig. 4 Principal component analysis and hierarchical cluster analysis results: a PC1 vs. PC2 plot of 859 heroin samples. b Hierarchical cluster
analysis performed using the selected PC coordinates. The 36 samples of the calibration set are displayed in red
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height to get significant p values which indicated that
clusterings were data-driven. This height was found to be
equal to 20.0.
Evaluation of transfer model predictive abilities
To evaluate the quality (i.e., predictive abilities) of the
transfer models, the frequency of correct classification was
computed on the corresponding local PCA–HCA dendro-
gram cut at the height mentioned above. When the tested
“GC-like” sample (i.e., a heroin analyzed by UHPLC–MS/
MS after data transformation) was identified in the same
final cluster as the GC-MS heroin sample in the local
dendrogram, the transfer of heroin profile coming from
UHPLC–MS/MS was considered successful. On this basis,
the predictive ability of each considered mathematical
model was quantified by counting the number of samples
where GC and “GC-like” data were found in the same
cluster, i.e., correctly transferred. Finally, this procedure
was carried out for all heroin samples of the calibration and
the validation sets, allowing for the determination of an
individual frequency of successful transfer for each math-
ematical model under investigation.
Results and discussion
Twelve components, including the seven alkaloids used in
heroin profiling, were detected during UHPLC–MS/MS
analysis. The separation and MS signal were optimized to
achieve good sensitivity, precision, and accuracy of the
method (see Fig. 5 for a UHPLC–MS/MS chromatogram).
UHPLC–MS/MS conditions
In these last few years, LC has evolved to improve
chromatographic performance. For this purpose, different
strategies have recently been developed to minimize the
analysis time while maintaining efficiency or to improve
efficiency without sacrificing analysis time [20, 21].
Among them, the use of column packed with sub-2-μm
particles becomes more popular, thanks to the recent
introduction of new instruments able to withstand ultra-
high pressures (up to 1,300 bar). The hyphenation with MS
detection is now well established, but besides the separation
aspect, the choice of an adequate ionization process is of
prime importance in condensed phase.
Determination of MS/MS conditions
In the present study, two different ionization sources were
initially evaluated, namely, ESI and APPI. The latter was
investigated because it is theoretically adapted to a wider
range of analyte polarity [22] despite it being well known to
provide slightly lower sensitivity than ESI. Various exper-
imental conditions were first evaluated in APPI: without
dopant, with acetone 5%, toluene 5%, and chlorobenzene
5% [23]. Dopant was added to enhance the ionization of
less polar analytes through charge exchange with dopant
radical cations. In the presence or absence of dopant, it was
possible to detect heroin, impurities from opium, solid
diluents, and impurities which arise from acetylation of
opium alkaloids, except acetylthebaol, the most apolar
compound, which was surprisingly not ionized with our
APPI source.
In a second step, ESI was evaluated. After optimizing
MS parameters, ionization of all compounds of interest,
even acetylthebaol, was possible. The sensitivity (in terms
of signal-to-noise ratio) was on average tenfold higher in
ESI compared to APPI, as reported elsewhere [24]. It is,
however, worth mentioning that ionization of acetylthebaol
was critical in ESI and cone voltage (CV) should be
carefully selected to avoid in-source fragmentation. Indeed,
the peak height drops when increasing CV beyond 20 V,
while the peak was not detected anymore at 50 V. Thus,
optimal CV for acetylthebaol was set at 20 V.
Using optimal ESI settings reported in “UHPLC–MS/
MS instrumentation”, product ion scans were acquired with
collision energies ranging between 10 and 60 eV, and the
two most intense transitions were selected for each
monitored precursor m/z. The optimal transitions as well
as the corresponding collision energies were reported in
Fig. 5 BPI (base peak intensity) chromatogram of the UHPLC–MS/
MS separation obtained after optimization of the chromatographic
separation for the 12 compounds of interest. Column: Acquity BEH
Shield RP18 50×2.1 mm, 1.7 μm, T=30 °C, F=500 μL/min, pH 9.
Gradient from 27% to 69.5% MeOH in 3.48 min, followed by a step
at 69.5% for 0.52 min. Peak identity: 1 paracetamol, 2 caffeine, 3
meconine, 4 morphine, 5 phenacetin, 6 6-MAM, 7 procaine, 8 heroin,
9 acetylcodeine, 10 papaverine, 11 noscapine, 12 acetylthebaol
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Table 2. Regarding optimal SRM transitions, the selection
was made in agreement with data from the literature
[25–27], while the explanation of fragmentation pathways
is out of the scope of the present paper.
Optimization of UHPLC separation
To reach suitable chromatographic selectivity and avoid
ion suppression or enhancement effects arising from the
co-elution of several compounds, the mobile phase pH
(i.e., pH of 8.0, 8.5, and 9), temperature (i.e., 30 and
50 °C), organic modifier (i.e., acetonitrile and methanol),
and stationary phase (i.e., Acquity BEH C18 and Acquity
BEH Shield RP18) were tuned during chromatographic
method development with a 100 μg/mL heroin sample
containing all analytes and further spiked with 1 μg/mL
of paracetamol, caffeine, phenacetin, morphine, and
procaine. For all these combinations of parameters,
representing 24 set of conditions, two gradient experi-
ments from 5% to 95% in 4.8 and 14.4 min were carried
out at a flow rate of 500 μL/min. Then, data were
computed in HPLC modeling software to find out the
best separation.
A first remark concerns the choice of pH. It is generally
well established that LC-MS separations of basic drugs,
such as those investigated in the heroin profiling, should
be carried out in acidic conditions to maximize sensitivity
with fully ionized molecules. However, in these chromato-
graphic conditions, poor chromatographic performance was
obtained, leading to detrimental resolution. For this reason,
basic pH was preferentially selected as it allows higher
selectivity and retention, but also better sensitivity, as
recently demonstrated with a mixture of drugs and
metabolites eluted at pH 9 [28]. This behavior was
attributed to a better desolvatation when analytes were
eluted with a high proportion of organic solvent. In the
present study, the pH has a strong influence on the
separation quality because most of compounds possess
pKa close to the investigated pH. For this separation, the
highest pH value was found to be beneficial, whatever the
temperature, nature of mobile, and stationary phases.
However, as the column lifetime can be reduced in too
aggressive conditions (i.e., the Acquity BEH Shield
RP18 can theoretically be used up to pH 11 because of
ethylene bridges inside the silica matrix, which prevent
its dissolution), more alkaline pH values were avoided.
Regarding the choice of mobile phase temperature, the
interest of working at 50 vs. 30 °C was evaluated. As
shown by Nguyen et al. [29], faster separations can be
attained, with a reasonable backpressure in UHPLC at
higher temperature. However, in the present study, selec-
tivity was slightly lower at 50 vs. 30 °C, particularly for
the separation of heroin (one of the largest peaks),
acetylcodeine, and papaverine. Most importantly, the
stability of the chromatographic support when simulta-
neously increasing temperature and pH becomes critical.
Thus, the separation was preferentially carried out at 30 °C, at
pH 9, to avoid such degradation issue.
Two organic modifiers (i.e., methanol and acetonitrile)
were evaluated, and methanol provided the best selectivity,
particularly for the critical separation of heroin/papaverine/
acetylcodeine. In addition, because of the recent acetonitrile
shortage, methanol appeared as the solvent of choice to
limit experimental cost [30]. The only drawback associated
with the use of methanol in UHPLC is its elevated
viscosity, generating higher backpressure. However, as the
flow rate was 500 μL/min and column length equals
50 mm, backpressure was always lower than 700 bar.
Finally, two columns from the same provider (Acquity
BEH C18 and Acquity BEH Shield RP18) were compared
to evaluate the selectivity between the 12 detected
compounds (i.e., seven investigated alkaloids, two co-
extracted alkaloids, and three solid diluents). A significant
difference was observed between these two stationary
phases. The C18 Shield material, containing an embedded
carbamate group, appeared to be the most interesting one,
particularly for the critical separation of heroin, papaverine,
and acetylcodeine. Thus, this material was selected to reach
the optimal separation.
In conclusion, the best separation of the 12 analytes of
interest in UHPLC was achieved with an Acquity BEH
Shield RP18 50×2.1 mm, 1.7-μm column operating at
30 °C, with a flow rate of 500 μL/min. The optimal
gradient found with HPLC optimization software varies
from 27% to 69.5% MeOH in 3.48 min, followed by a
step at 69.5% for 0.52 min and was carried out at pH 9.
For MS detection, dwell times for each SRM transition
were adjusted in agreement with the required sensitivity.
As the response was sufficient for most of the com-
pounds, the lowest possible dwell time, 5 ms, was
selected for most of the analytes. On the other hand,
dwell times of 40 and 50 ms were selected for meconine
and acethylthebaol, respectively, because these two
compounds provided the lowest signal-to-noise ratio.
Using this strategy, it was possible to maintain an
acquisition rate of 5 Hz and thus obtain reliable data
even with thin UHPLC peaks (at least 15–20 data points
across the peaks).
Compared with the original GC-MS separation carried
out in around 23 min (Fig. 1), the optimized UHPLC–MS/
MS strategy allows a reduction of analysis time down to
only 4 min (Fig. 5), while the minimal resolution remains at
least equal to 1.5 in UHPLC–MS/MS (lower resolution
observed for the critical pair, 6-MAM/procaine). Two
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transitions by compounds were recorded to increase
selectivity (Fig. 6), and the most intense transition was
selected to integrate the peaks and conduct the transfer. In
addition, the absence of sample derivatization prior to the
analysis leads to conclude that UHPLC–MS/MS represents
the fastest analytical approach for heroin profiling.
Transfer results
Table 4 summarizes the results obtained for the transfer of
UHPLC–MS/MS data to the GC-MS database. For a given
tested model, adjusted R2 and Q2 of the seven MLRs (one
MLR by compound) were averaged to estimate the overall
predictive abilities of each model. In fact, the frequency of
successful transfer of the validation set is much more
representative of the predictive abilities of each model than
for the calibration set which is used for the establishment of
the transfer models (B.5.). Most models offered relatively
low predictive abilities and some of them were overfitted.
Indeed, the observed differences between the frequency of
successful transfer for the calibration (e.g., 86.1% for the
quadratic model) and validation sets (e.g., 68.2% for the
quadratic model) clearly illustrated this problem. A corre-
lation can be observed between the mean adjusted R2 and
the calibration set frequency of successful transfer. This
means that if the model was well adjusted on the calibration
Fig. 6 Extracted ion chromatogram of the UHPLC–MS/MS separa-
tion of an unknown heroin. Two transititions of each of the seven
major alkaloids of heroin were followed by MS/MS using the
conditions described in Table 3. Star superscript indicates the
transisitions used for peak integration. Analytical conditions were
similar to Fig. 5
2728 B. Debrus et al.
points (relatively high adjusted R2), it can be assumed that
the “GC-like” samples coming from the calibration points
will be successfully transferred. However, no correlation
was observed between mean Q2 and the validation set
frequency of successful transfer. Linear and poly-linear
models gave reasonably good frequencies of successful
transfer and respectively offered better results than qua-
dratic and poly-quadratic models. In this case, the addition
of quadratic (or cubic) terms in transfer models did not
increase the frequency of successful transfer. The frequency
of successful transfer directly depends on the height at
which dendrograms were cut (see “Significant clustering
height calculation” and “Evaluation of transfer model
predictive abilities”). As the frequency quickly increased
when the cutting height was slightly augmented, high
frequencies of successful transfer were obtained with
relatively low cutting height.
However, it is important to keep in mind that the
ionization sources of the two analytical techniques were
very different: ESI operating at atmospheric pressure (i.e.,
soft ionization mode) and EI in vacuum conditions (i.e.,
hard ionization mode) for UHPLC–MS/MS and GC-MS,
respectively. Despite this dissimilarity, the simplified
model, which includes the mathematical terms allowing
the maximization of the adjusted R2 (mainly linear terms),
was able to accurately predict the samples included in the
validation set (see Table 4).
Furthermore, the current size of the used sets already
allowed a very good preliminary estimation of model
predictive ability even if increasing the size of calibration
set and especially validation set could also allow a better
evaluation of their abilities. In addition, simplified models
were uncomplicated to manage as only three terms were
generally selected during the Pareto analysis. These seven
simplified models (one for each compound) offered a
probability of 95.5% of successful transfer for future heroin
samples.
Conclusion
The transfer of results from an analytical technique to
another is a delicate task that requires paying special
attention to the physical and chemical phenomena that
regulate analytical signals obtained and to the statistical
techniques employed. Indeed, the transfer complexity
depends on the similarity of data nature and, particularly
in the case of MS detection, on the ionization sources. In
this context, simplified models with an average of three
mathematical terms have achieved very promising results
(i.e., almost totally successful transfer), paving the way
for the methods to be implemented for this type of
transfer.
GC-MS currently remains the technique of choice to
achieve heroin profiling, mainly because this technique
is generally present in most analytical chemistry, toxi-
cology, and forensic science laboratories. However,
UHPLC–MS/MS offers enormous benefit to avoid the
derivatization step, to move forward to the trend of “fast
forensic,” and easily achieve quantification of investigated
alkaloids. In light of the results, the transfer of heroin profiling
to UHPLC–MS/MS could thus be considered in the near
future.
In conclusion, a growing interest could be paid to
explore other pretreatments and mathematical models while
evaluating the additional profit they could bring in the
transfer of analytical techniques. Until this potential
improvement, the sequential use of PCA and HCA has
already been proven to be a simple and powerful
unsupervised statistical tool that achieves meaningful
classifications (data-driven clustering) with respect to the
data set studied in this work. The present transfer strategy
can therefore be regarded as a very promising starting point
for future statistical methodologies in the framework of the
transfer of other data sets (e.g., cocaine and other illicit
drugs) and/or new analytical techniques.
Table 4 Model mean adjusted coefficients of determination (adjusted R2), mean coefficient of prediction (Q2), and frequency of succesful transfer
obtained for the calibration set and the validation set
Model name Calibration set (36 samples) Validation set (22 samples)
Mean adjusted R2 Mean Q2 Frequency of succesfull transfer (%) Frequency of succesfull transfer (%)
Linear 0.695 0.627 80.6 81.8
Quadratic 0.732 0.671 86.1 68.2
Cubic 0.728 0.646 86.1 68.2
Poly-linear 0.802 0.750 94.4 81.8
Poly-quadratic 0.871 0.842 97.2 68.2
Complete 0.971 0.902 100.0 63.6
Simplified 0.803 0.725 97.2 95.5
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Appendix
The fully described equations of the seven simplified
models are given here.
MECGC¼ 0:151þ 0:990MECUHPLCþ0:056ACUHPLC
ACGC¼ 0:217þ 1:087ACUHPLC  0:332 PAPUHPLC
AcTBGC¼ 0:264þ 1:129AcTBUHPLCþ0:176 PAPUHPLC  0:069AcTBUHPLC MAMUHPLC  0:074AcTBUHPLC2  PAPUHPLC
MAMGC¼ 0:136þ 0:882MAMUHPLC  0:234AcTBUHPLC
DAMGC¼ 0:246þ 0:546DAMUHPLCþ0:442ACUHPLC  0:261MAMUHPLC
PAPGC¼ 0:607þ 0:207 PAPUHPLCþ0:289NOSUHPLC  0:034MECUHPLC2þ0:225 PAPUHPLC MAMUHPLC
NOSGC¼ 0:359þ 0:729NOSUHPLC  0:220ACUHPLCþ0:315NOSUHPLC  PAPUHPLC
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